NCT00002868View on ClinicalTrials.gov

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

744

Participants

Timeline

Start Date

November 20, 1997

Primary Completion Date

March 31, 2004

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

DRUG

busulfan

DRUG

cytarabine

DRUG

etoposide

DRUG

hydroxyurea

DRUG

idarubicin

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (3)

07601

Hackensack University Medical Center, Hackensack

07701

Riverview Medical Center - Booker Cancer Center, Red Bank

G4 0SF

Royal Infirmary, Glasgow

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002868 - Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter